Page last updated: 2024-10-28

ifenprodil and Brain Damage, Chronic

ifenprodil has been researched along with Brain Damage, Chronic in 2 studies

ifenprodil: NMDA receptor antagonist

Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Picconi, B1
Tortiglione, A1
Barone, I1
Centonze, D1
Gardoni, F1
Gubellini, P1
Bonsi, P1
Pisani, A1
Bernardi, G1
Di Luca, M1
Calabresi, P1
Goto, K1
Suekawa, M1
Aburada, M1
Hosoya, E1

Other Studies

2 other studies available for ifenprodil and Brain Damage, Chronic

ArticleYear
NR2B subunit exerts a critical role in postischemic synaptic plasticity.
    Stroke, 2006, Volume: 37, Issue:7

    Topics: Animals; Brain Damage, Chronic; Cerebral Infarction; Cerebrovascular Circulation; Corpus Striatum; D

2006
[Pharmacological study of TJ-8007 (Tsumura-Zokumeito) (I): Protective effects of TJ-8007 against anoxic brain damage].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1987, Volume: 89, Issue:6

    Topics: Animals; Brain Damage, Chronic; Coma; Drugs, Chinese Herbal; Hypoxia, Brain; Male; Medicine, Chinese

1987